120 related articles for article (PubMed ID: 9352572)
1. Effects of thioridazine, an inhibitor of CYP2D6, on the steady-state plasma concentrations of the enantiomers of mianserin and its active metabolite, desmethylmianserin, in depressed Japanese patients.
Yasui N; Tybring G; Otani K; Mihara K; Suzuki A; Svensson JO; Kaneko S
Pharmacogenetics; 1997 Oct; 7(5):369-74. PubMed ID: 9352572
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective determination of mianserin and its desmethyl metabolite in plasma during treatment of depressed Japanese patients.
Tybring G; Otani K; Kaneko S; Mihara K; Fukushima Y; Bertilsson L
Ther Drug Monit; 1995 Oct; 17(5):516-21. PubMed ID: 8585116
[TBL] [Abstract][Full Text] [Related]
3. The CYP2D6 genotype and plasma concentrations of mianserin enantiomers in relation to therapeutic response to mianserin in depressed Japanese patients.
Mihara K; Otani K; Tybring G; Dahl ML; Bertilsson L; Kaneko S
J Clin Psychopharmacol; 1997 Dec; 17(6):467-71. PubMed ID: 9408809
[TBL] [Abstract][Full Text] [Related]
4. Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine.
Eap CB; Lima CA; Macciardi F; Woggon B; Powell K; Baumann P
Ther Drug Monit; 1998 Feb; 20(1):7-13. PubMed ID: 9485547
[TBL] [Abstract][Full Text] [Related]
5. Correlation between steady-state plasma concentrations of mianserin and trazodone in depressed patients.
Otani K; Tybring G; Mihara K; Yasui N; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
Eur J Clin Pharmacol; 1998 Jan; 53(5):347-9. PubMed ID: 9516035
[TBL] [Abstract][Full Text] [Related]
6. Determination of the enantiomers of mianserin, desmethylmianserin, and 8-hydroxymianserin in the plasma and urine of mianserin-treated patients.
Eap CB; Powell K; Campus-Souche D; Monney C; Baettig D; Taeschner W; Baumann P
Chirality; 1994; 6(7):555-63. PubMed ID: 7986669
[TBL] [Abstract][Full Text] [Related]
7. Steady-state plasma concentrations of mianserin and its major active metabolite, desmethylmianserin.
Otani K; Sasa H; Kaneko S; Kondo T; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):113-7. PubMed ID: 8503138
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbamazepine coadministration on plasma concentrations of the enantiomers of mianserin and of its metabolites.
Eap CB; Yasui N; Kaneko S; Baumann P; Powell K; Otani K
Ther Drug Monit; 1999 Apr; 21(2):166-70. PubMed ID: 10217335
[TBL] [Abstract][Full Text] [Related]
9. Prediction of plasma concentrations of mianserin and desmethylmianserin at steady state from those after an initial dose of mianserin.
Otani K; Mihara K; Okada M; Tanaka O; Kaneko S; Fukushima Y
Ther Drug Monit; 1993 Apr; 15(2):118-21. PubMed ID: 8503139
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of trazodone metabolism by thioridazine in humans.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Ishida M; Mihara K; Kondo T; Sugawara K; Fukushima Y
Ther Drug Monit; 1995 Aug; 17(4):333-5. PubMed ID: 7482685
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective disposition of mianserin is related to debrisoquin hydroxylation polymorphism.
Dahl ML; Tybring G; Elwin CE; Alm C; Andreasson K; Gyllenpalm M; Bertilsson L
Clin Pharmacol Ther; 1994 Aug; 56(2):176-83. PubMed ID: 8062494
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Steady-state Plasma Concentrations of Enantiomeric Mirtazapine and its Desmethylated Metabolites in Japanese Psychiatric Patients.
Hayashi Y; Watanabe T; Aoki A; Ishiguro S; Ueda M; Akiyama K; Kato K; Inoue Y; Tsuchimine S; Yasui-Furukori N; Shimoda K
Pharmacopsychiatry; 2015 Nov; 48(7):279-85. PubMed ID: 26595747
[TBL] [Abstract][Full Text] [Related]
13. Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
Lind AB; Reis M; Bengtsson F; Jonzier-Perey M; Powell Golay K; Ahlner J; Baumann P; Dahl ML
Clin Pharmacokinet; 2009; 48(1):63-70. PubMed ID: 19071885
[TBL] [Abstract][Full Text] [Related]
14. Analytical method development and validation of mianserin hydrochloride and its metabolite in human plasma by LC-MS.
Chauhan B; Rani S; Guttikar S; Zope A; Jadon N; Padh H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):69-74. PubMed ID: 16006201
[TBL] [Abstract][Full Text] [Related]
15. Subjective side effects of mianserin in relation to plasma concentrations of mianserin and desmethylmianserin.
Otani K; Sasa H; Higuchi H; Kaneko S; Hishikawa Y; Fukushima Y
Ther Drug Monit; 1992 Jun; 14(3):190-3. PubMed ID: 1412603
[TBL] [Abstract][Full Text] [Related]
16. Increases in plasma concentration of m-chlorophenylpiperazine, but not trazodone, with low-dose haloperidol.
Mihara K; Otani K; Ishida M; Yasui N; Suzuki A; Ohkubo T; Osanai T; Kaneko S; Sugawara K
Ther Drug Monit; 1997 Feb; 19(1):43-5. PubMed ID: 9029745
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of mirtazapine: enantioselective effects of the CYP2D6 ultra rapid metabolizer genotype and correlation with adverse effects.
Brockmöller J; Meineke I; Kirchheiner J
Clin Pharmacol Ther; 2007 May; 81(5):699-707. PubMed ID: 17329996
[TBL] [Abstract][Full Text] [Related]
18. Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
Berecz R; de la Rubia A; Dorado P; Fernández-Salguero P; Dahl ML; LLerena A
Eur J Clin Pharmacol; 2003 May; 59(1):45-50. PubMed ID: 12682803
[TBL] [Abstract][Full Text] [Related]
19. Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Jaquenoud Sirot E; Harenberg S; Vandel P; Lima CA; Perrenoud P; Kemmerling K; Zullino DF; Hilleret H; Crettol S; Jonzier-Perey M; Golay KP; Brocard M; Eap CB; Baumann P
J Clin Psychopharmacol; 2012 Oct; 32(5):622-9. PubMed ID: 22926595
[TBL] [Abstract][Full Text] [Related]
20. Chirality in the new generation of antidepressants: stereoselective analysis of the enantiomers of mirtazapine, N-demethylmirtazapine, and 8-hydroxymirtazapine by LC-MS.
Paus E; Jonzier-Perey M; Cochard N; Eap CB; Baumann P
Ther Drug Monit; 2004 Aug; 26(4):366-74. PubMed ID: 15257065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
